Financial Summary (All financials)
| In millions of EUR, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 18,611.0 | 13,978.5 | 11,820.0 | 10,944.0 | 8,962.7 | 932.3 | 6,287.4 | 5,856.3 |
| Revenue growth | 33.1% | 18.3% | 8.0% | 22.1% | 861.4% | -85.2% | 7.4% | 11.6% |
| Cost of goods sold | -3,507.6 | -2,759.7 | -2,685.0 | -2,648.6 | -2,257.8 | -2,213.0 | -1,994.7 | -2,057.6 |
| Gross profit | 22,118.6 | 16,738.2 | 14,505.0 | 13,592.6 | 11,220.5 | 3,145.3 | 8,282.1 | 7,913.9 |
| Gross margin | 118.8% | 119.7% | 122.7% | 124.2% | 125.2% | 337.4% | 131.7% | 135.1% |
| Selling, general and administrative | 3,818.1 | 3,272.6 | 2,826.8 | 2,412.2 | 2,029.0 | 1,758.2 | 1,604.0 | 402.8 |
| Research and development | 2,547.0 | 2,200.8 | 1,968.5 | 1,575.9 | 1,259.7 | 1,105.8 | 1,068.1 | 1,074.0 |
| General and administrative | 3,092.5 | 2,727.7 | 2,306.3 | 1,924.2 | 1,612.4 | 1,279.6 | | |
| EBITA | 7,094.1 | 4,239.7 | 2,924.4 | 3,075.2 | 2,561.9 | 1,822.0 | 1,616.3 | 1,326.1 |
| EBITA margin | 38.1% | 30.3% | 24.7% | 28.1% | 28.6% | 195.4% | 25.7% | 22.6% |
| Amortization of intangibles | 133.0 | 123.5 | 115.4 | 103.7 | 105.5 | 63.5 | 51.2 | 43.9 |
| EBIT | 6,961.1 | 4,116.2 | 2,809.0 | 2,971.5 | 2,456.4 | 1,758.5 | 1,565.1 | 1,282.2 |
| EBIT margin | 37.4% | 29.4% | 23.8% | 27.2% | 27.4% | 188.6% | 24.9% | 21.9% |
| Pre-tax income | 6,705.5 | 4,016.6 | 2,765.8 | 2,937.0 | 2,389.4 | 1,792.2 | 1,548.6 | 1,273.6 |
| Income taxes | 1,021.4 | 551.5 | 191.7 | 351.6 | -306.0 | 234.4 | 161.4 | 77.0 |
| Tax rate | 15.2% | 13.7% | 6.9% | 12.0% | | 13.1% | 10.4% | 6.0% |
| Net income | 5,883.2 | 3,553.7 | 2,592.3 | 2,591.6 | 2,066.7 | 1,557.8 | 1,387.2 | 1,196.6 |
| Net margin | 31.6% | 25.4% | 21.9% | 23.7% | 23.1% | 167.1% | 22.1% | 20.4% |
| |
| Diluted EPS | $14.34 | $8.48 | $6.15 | $6.08 | $4.79 | $3.64 | $3.21 | $2.72 |
| Shares outstanding (diluted) | 410.4 | 419.1 | 421.6 | 426.4 | 431.6 | 427.7 | 432.6 | 439.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|